Identification of PLA2G6 variants in a Chinese patient with Parkinson's disease
暂无分享,去创建一个
H. Deng | Wen Zheng | Zhi Song | Huan Li | Zhijian Yang | Jiangang Wang | L. Yuan | Xinyue Deng | Yan Yang
[1] H. Deng,et al. The role of the PLA2G6 gene in neurodegenerative diseases , 2023, Ageing Research Reviews.
[2] Bicheng Yang,et al. Identification of a Novel Nonsense Mutation in PLA2G6 and Prenatal Diagnosis in a Chinese Family With Infantile Neuroaxonal Dystrophy , 2022, Frontiers in Neurology.
[3] Hong-Fu Li,et al. Clinical Characterization and Founder Effect Analysis in Chinese Patients with Phospholipase A2-Associated Neurodegeneration , 2022, Brain sciences.
[4] K. Kumar,et al. Monogenic Parkinson’s Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing , 2022, Genes.
[5] G. Stevanin,et al. Insights into Clinical, Genetic, and Pathological Aspects of Hereditary Spastic Paraplegias: A Comprehensive Overview , 2021, Frontiers in Molecular Biosciences.
[6] J. Hardy,et al. Dissecting the Phenotype and Genotype of PLA2G6‐Related Parkinsonism , 2021, Movement disorders : official journal of the Movement Disorder Society.
[7] H. Deng,et al. Genetic Analysis and Literature Review of SNCA Variants in Parkinson's Disease , 2021, Frontiers in Aging Neuroscience.
[8] Qingshan Wang,et al. Interplay among norepinephrine, NOX2, and neuroinflammation: key players in Parkinson’s disease and prime targets for therapies , 2021, Ageing and Neurodegenerative Diseases.
[9] D. Rubinsztein,et al. Autophagy in ageing and ageing-related neurodegenerative diseases , 2021, Ageing and Neurodegenerative Diseases.
[10] Sonja W. Scholz,et al. Challenges in the diagnosis of Parkinson's disease , 2021, The Lancet Neurology.
[11] Y. Shimo,et al. PLA2G6 variants associated with the number of affected alleles in Parkinson’s disease in Japan , 2020, Neurobiology of Aging.
[12] J. Jankovic,et al. Parkinson’s disease: etiopathogenesis and treatment , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[13] Pei-Lung Chen,et al. Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review , 2020, BMC Neurology.
[14] Andrew B Singleton,et al. The genetic architecture of Parkinson's disease , 2020, The Lancet Neurology.
[15] W. Ni,et al. Novel PLA2G6 mutations and clinical heterogeneity in Chinese cases with phospholipase A2-associated neurodegeneration. , 2018, Parkinsonism & related disorders.
[16] R. Gross,et al. The structure of iPLA2β reveals dimeric active sites and suggests mechanisms of regulation and localization , 2018, Nature Communications.
[17] C. Paisán-Ruiz,et al. Pla2g6 Deficiency in Zebrafish Leads to Dopaminergic Cell Death, Axonal Degeneration, Increased β-Synuclein Expression, and Defects in Brain Functions and Pathways , 2018, Molecular Neurobiology.
[18] S. Lai,et al. PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway , 2017, Oncotarget.
[19] S. Bohlega,et al. Clinical heterogeneity of PLA2G6-related Parkinsonism: analysis of two Saudi families , 2016, BMC Research Notes.
[20] M. Kirber,et al. Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson's disease , 2016, Nature Communications.
[21] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[22] X. Lei,et al. Calcium-independent phospholipases A2 and their roles in biological processes and diseases , 2015, Journal of Lipid Research.
[23] J. Hardy,et al. Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction , 2015, Brain : a journal of neurology.
[24] Yang Zhang,et al. Protein-ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment , 2013, Bioinform..
[25] Yang Zhang,et al. BioLiP: a semi-manually curated database for biologically relevant ligand–protein interactions , 2012, Nucleic Acids Res..
[26] Hong‐Mei Liu,et al. Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease. , 2013, Parkinsonism & related disorders.
[27] Rou-shayn Chen,et al. PLA2G6 mutations in PARK14‐linked young‐onset parkinsonism and sporadic Parkinson's disease , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[28] S. Bruley des Varannes,et al. Parkinson disease , 2011, Neurology.
[29] A. Brice,et al. What genetics tells us about the causes and mechanisms of Parkinson's disease. , 2011, Physiological reviews.
[30] Tatiana Foroud,et al. Genetics of Parkinson disease , 2004, Genetics in Medicine.
[31] P. Kotzbauer,et al. Catalytic Function of PLA2G6 Is Impaired by Mutations Associated with Infantile Neuroaxonal Dystrophy but Not Dystonia-Parkinsonism , 2010, PloS one.
[32] D. Hernandez,et al. Characterization of PLA2G6 as a locus for dystonia‐parkinsonism , 2008, Annals of neurology.
[33] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[34] B. Kennedy,et al. The human calcium-independent phospholipase A2 gene multiple enzymes with distinct properties from a single gene. , 1999, European journal of biochemistry.
[35] B. Kennedy,et al. Multiple Splice Variants of the Human Calcium-independent Phospholipase A2 and Their Effect on Enzyme Activity* , 1998, The Journal of Biological Chemistry.